Literature DB >> 1276175

Effect of clofibrate treatment on carnitine acyltransferases in different subcellular fractions of rat liver.

M T Kahonen.   

Abstract

The subcellular distribution of carnitine acetyl-, octanoyl-, and palmitoyl- transferase in the livers of normal and clofibrate-treated male rats was studied with isopycnic sucrose density gradient fractionation. In normal liver 48% of total carnitine acetyltransferase activity was peroxisomal, 36% of the activity located in mitochondria and 16% in a membranous fraction containing microsomes. Carnitine octanoyltransferase and carnitine palmitoyltransferase were confined almost totally (77--81%) to mitochondria in normal liver. Clofibrate treatment increased the total activity of carnitine acetyltransferase over 30 times, whereas the total activities of the other two transferases were increased only 5-fold. From the three different subcellular carnitine acetyltransferases the mitochondrial one was most responsive to clofibrate treatment, i.e. the rise in mitochondrial activity was over 70-fold as contrasted to the 6- and 14-fold rises in peroxisomal and microsomal activities, respectively. After treatment mitochondria contained 79% of total activity. It is concluded that the clofibrate-induced increase of carnitine acetyltransferase activity is not due to the peroxisomal proliferation that occurs during clofibrate treatment. The rise in peroxisomal activity contributed only 8% to the total increase. After clofibrate treatment the greatest part of carnitine octanoyl- and palmitoyltransferase activities were located in mitochondria but a considerable amount of both activities was found also in the soluble fraction of liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276175     DOI: 10.1016/0304-4165(76)90199-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Carnitine acyltransferase and acyl-coenzyme A hydrolase activities in human liver. Quantitative analysis of their subcellular localization.

Authors:  M Bronfman; F Leighton
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

2.  Detection of peroxisomal fatty acyl-coenzyme A oxidase activity.

Authors:  N C Inestrosa; M Bronfman; F Leighton
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

3.  Induction of carnitine acetyltransferase by clofibrate in rat liver.

Authors:  B Mittal; C K Kurup
Journal:  Biochem J       Date:  1981-01-15       Impact factor: 3.857

4.  Inducing effect of clofibrate on alkaline phosphatase and histidine-glyoxylate aminotransferase in rat liver.

Authors:  L F Panchenko; S V Popova; V D Antonenkov
Journal:  Experientia       Date:  1982-04-15

5.  Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs.

Authors:  P S Brady; K A Marine; L J Brady; R R Ramsay
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

6.  Partial purification and immunoreactivity of an 80 000-molecular-weight polypeptide associated with peroxisome proliferation in rat liver.

Authors:  M K Reddy; P F Hollenberg; J K Reddy
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

7.  Isolation and identification of aliphatic short-chain acylcarnitines from beef heart: possible role for carnitine in branched-chain amino acid metabolism.

Authors:  L L Bieber; Y R Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

8.  Effect of clofibric acid on the molecular species composition of diacyl glycerophosphocholine of rat liver microsomes.

Authors:  Y Nakagawa; K Waku; A Hirose; Y Kawashima; H Kozuka
Journal:  Lipids       Date:  1986-10       Impact factor: 1.880

9.  Divergent sequences in the 5' region of cDNA suggest alternative splicing as a mechanism for the generation of carnitine acetyltransferases with different subcellular localizations.

Authors:  O Corti; S DiDonato; G Finocchiaro
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.